Pharmaceutical News

RSS

3D drug printers could help personalize medications in the future

Chocolate-flavored pills for children who hate taking medicine.

25 Jun 2024

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy", to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.

25 Jun 2024

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer Center.

25 Jun 2024

Study reveals high rates of aspirin use for CVD prevention among older adults

A survey representing about 150 million adults annually suggests that aspirin use for primary prevention of cardiovascular disease (CVD) remains prevalent among older adults, contrary to recommendations from the American College of Cardiology and the American Heart Association.

24 Jun 2024

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Sobi® today announced the European Commission has granted Marketing Authorization for ALTUVOCT™ (efanesoctocog alfa), for the treatment and prevention of bleeds and perioperative prophylaxis in hemophilia A. ALTUVOCT is a high-sustained factor VIII replacement therapy for all ages and any disease severity.

22 Jun 2024

Semaglutide weight loss results linked to diabetes severity

Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.

21 Jun 2024

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.

20 Jun 2024

WEHI spinout aims to revolutionize the development of cancer drugs

Australia has cemented its role in becoming a major player in the next generation of medicines with the launch of Ternarx – a globally competitive biotechnology company dedicated to finding new treatments for hard-to-treat cancers.

20 Jun 2024

WHO issues medical product alert on falsified semaglutides

The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of type 2 diabetes and obesity in some countries.

20 Jun 2024

Enlarged prostate medications may also decrease the risk for dementia with Lewy bodies

A new study suggests that certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies (DLB).

19 Jun 2024

Angiotensin receptor blockers found to lower epilepsy risk, new study reveals

A recent study published in JAMA Neurology shows that angiotensin receptor blockers, a class of blood pressure drugs, reduce the risk of developing epilepsy, especially in older adults and stroke survivors.

18 Jun 2024

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

A recent study from the PIONEER REAL Netherlands trial demonstrated that oral semaglutide effectively manages type 2 diabetes and supports weight loss in adults.

18 Jun 2024

Future Labs Live draws experts and leaders from science, academia, start-ups, FMGC, chemical, and agricultural industries to its conference floor in Basel, Switzerland

Sessions will cover topics from digital transformation to connectivity & collaboration, lab operations & efficiency, and more.

From Future Labs Live Basel 2024 18 Jun 2024

Amoxicillin outperforms penicillin V in treating pediatric pneumonia, study finds

A recent study confirmed amoxicillin's lower risk of treatment failure compared to penicillin V in treating pediatric pneumonia, with no difference in severe complications.

18 Jun 2024

Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

A recent review in Diabetes Care evaluates the efficacy and safety of GLP-1 receptor agonists for type 2 diabetes and obesity, exploring their potential for new medical indications.

18 Jun 2024

Study: Out-of-pocket costs impact naloxone access

Patients are less likely to fill prescriptions for naloxone when they face increases in out-of-pocket costs, according to research by the University of Michigan.

13 Jun 2024

Dose reduction of glucocorticoids in systemic lupus erythematosus

Glucocorticoids are a mainstay of treatment for systemic lupus erythematosus (SLE). But due to long-term adverse effects, dose reduction is becoming a crucial part of treat-to-target management goals.

13 Jun 2024

Pre-surgery GLP-1 agonists reduce post-operative risks in extreme obesity

A combination of GLP-1 agonists taken before metabolic and bariatric surgery may help patients with extreme obesity lower the risk of post-operative complications, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery 2024 Annual Scientific Meeting.

13 Jun 2024

Combining donepezil and memantine extends lives of Alzheimer's patients, study finds

Alzheimer's disease is the world's most common neurodegenerative disease, affecting more than 50 million people globally.

12 Jun 2024

Deep learning revives ancient peptides to battle antibiotic resistance

Researchers used deep learning to resurrect antibiotic peptides from extinct organisms, offering new solutions for combating antibiotic resistance.

12 Jun 2024

Previous
1
...
13
14
15
16
17
18
19
...
1433
Next

Pharmaceutical News

3D drug printers could help personalize medications in the future

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

Study reveals high rates of aspirin use for CVD prevention among older adults

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Semaglutide weight loss results linked to diabetes severity

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

WEHI spinout aims to revolutionize the development of cancer drugs

WHO issues medical product alert on falsified semaglutides

Enlarged prostate medications may also decrease the risk for dementia with Lewy bodies

Angiotensin receptor blockers found to lower epilepsy risk, new study reveals

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

Future Labs Live draws experts and leaders from science, academia, start-ups, FMGC, chemical, and agricultural industries to its conference floor in Basel, Switzerland

Amoxicillin outperforms penicillin V in treating pediatric pneumonia, study finds

Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

Study: Out-of-pocket costs impact naloxone access

Dose reduction of glucocorticoids in systemic lupus erythematosus

Pre-surgery GLP-1 agonists reduce post-operative risks in extreme obesity

Combining donepezil and memantine extends lives of Alzheimer's patients, study finds

Deep learning revives ancient peptides to battle antibiotic resistance

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News